Blog: Colon cancer

Results from CareAcross Randomised Controlled Trial presented orally at ASCO 2024

At the 2024 ASCO congress, promising results of the prospective randomised controlled trial (RCT) conducted through the CareAcross service were shared in a mini-oral presentation.

Promising results in immunotherapy

Professor Håkan Mellstedt is a medical oncologist at the Cancer Center Karolinska in Sweden, with extensive clinical and academic experience. In this article, Prof. Mellstedt, also a member of our Scientific Committee, explains the basics of immunotherapy and key research being conducted across cancer types.

Colon cancer: treatment options, genetic testing and biomarkers

Colon cancer is one of the most common types of cancer. We asked Professor Hans-Joachim Schmoll, a member of the CareAcross Scientific Committee and a very experienced medical oncologist a few questions on treatment options, genetic testing and biomarkers.

Colon cancer: when should chemotherapy follow surgery?

Some patients with stage 2 colon cancer will recur after surgery. Our Chief Medical Officer provides detail on when post-surgery chemotherapy is likely to help treatment.